Nab-Paclitaxel/Bevacizumab/Carboplatin Chemotherapy in First-Line Triple Negative Metastatic Breast Cancer
Author:
Funder
Genentech
Celgene
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference23 articles.
1. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin Cancer Res,2007
2. Metastatic triple-negative breast cancer;Rakha;Clin Oncol (R Coll Radiol),2011
3. Emerging targeted therapies in triple-negative breast cancer;Crown;Ann Oncol,2012
4. Carboplatin in combination therapy for metastatic breast cancer;Perez;Oncologist,2004
5. A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma;Perez;Cancer,2000
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synergistic Anticancer Response via Docetaxel- and Oleanolic Acid-Loaded Albumin/Poly(lactide) Nanoparticles in Triple-Negative Breast Cancer;ACS Applied Nano Materials;2023-10-30
2. Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison;Clinical Breast Cancer;2023-04
3. The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies;International Journal of Molecular Sciences;2023-02-06
4. Current trends in the use of human serum albumin for drug delivery in cancer;Expert Opinion on Drug Delivery;2022-10-17
5. Design and Validation of Nanofibers Made of Self-Assembled Peptides to Become Multifunctional Stimuli-Sensitive Nanovectors of Anticancer Drug Doxorubicin;Pharmaceutics;2022-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3